•  
  •  
  •  
  •  

2025-11-25 17:57:38

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • DoT grants UL VNO-GMPCS to Nelco Ltd
  • Cybele Industries Ltd has sold land for Rs. 13.10 crore
  • Mangalam Drugs and Organics Ltd receives repeat export order worth Rs. 15 crore
  • Zydus receives final approval from USFDA for Verapamil Hydrochloride Extended-Release Tablets USP, 120 mg, 180 mg and 240 mg
  • Firstsource recognized as a 'Leader' in Digital Operations in ISG Provider LensĀ® 2025

Keywords Selected:  ANAROCK

Research

  • INR 45-90 Lakh 'Sweet Spot' for 36% Women Homebuyers - ANAROCK Survey
  • 2023 - More Smooth Sailing or Bumpy Ride for Indian Real Estate?
  • Top Trends That Shaped India's Housing Market in 2022
  • RBI's 35 Bps Rate Hike Won't Rock Housing Boat
  • IBC in Real Estate - Poor Resolution Rates but Superior Value Maximisation - Report
  • 3BHKs in Highest Demand for 44% Respondents - CII-ANAROCK Survey
  • Coworking Share in Office Real Estate at 20% in H1 2022 from 6% in 2021
  • Over 45 Data Centres Spanning ~13 Mn Sft to Boot Up in India by 2025-end
  • Monetary Policy - entering the red zone - Anuj Puri, ANAROCK
  • 41% Women Homebuyers in ANAROCK Survey opt for 3BHK, 26% Buying for Investment
  • Industry Reaction on RBI Monetary Policy
  • RBI's Unchanged Repo Rate Supports Homebuyers' Festive Cheer

Market Commentary

  • Unchanged Repo Rates A Boon for the Housing Market - Anuj Puri, Chairman - ANAROCK Group

Industry News

  • Housing Sales Rose 71% in 2021 To Reach 90% of Pre-COVID Levels, Launches Up 85% in Top 7 Cities - ANAROCK

Latest Post

  • DoT grants UL VNO-GMPCS to Nelco Ltd
  • Cybele Industries Ltd has sold land for Rs. 13.10 crore
  • Mangalam Drugs and Organics Ltd receives repeat export order worth Rs. 15 crore
  • Zydus receives final approval from USFDA for Verapamil Hydrochloride Extended-Release Tablets USP, 120 mg, 180 mg and 240 mg
  • Firstsource recognized as a 'Leader' in Digital Operations in ISG Provider LensĀ® 2025


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024